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In epidermis, keratinocytes in the basal cell layer differen-
tiate, lose their attachment to the underlying extracellular 
matrix, and form extensive intercellular adhesions as they 
stratify. The alterations in cell-matrix and cell-cell adhesion 
required for keratinocyte stratification result from changes in 
the expression of numerous adhesion molecules. Syndecan-1, 
a member of a family of cell-surface proteoglycans, is known 
to bind cells to interstitial matrix. Syndecan-1 localizes to 
specific layers of mouse epidermal keratinocytes; its expres-
sion is modest in the basal layer, heavy in the suprabasal 
layers, but absent from the most superficial, terminally dif-
ferentiated layers. This layer-specific difference suggests that 
syndecan-1 expression changes with keratinocyte differen-
tiation. To assess this hypothesis, syndecan-1 expression was 
T he outer protective barrier of the skin, the epidermis, is a stratified epithelium composed of layers of kerati-nocytes at increasing stages of differentiation. The mitotically active basal layer gives rise to differentiat-ing cells that migrate upward through the spinous and 
granular layers, become keratinized in the cornified layers, and are 
eventually sloughed from the skin as dead squames. This upward 
migration requires that cells destined to leave the basal layer break 
contact with the underlying extracellular matrix and form new 
associations with suprabasal cells, presumably through specific cell-
cell contacts. Compared to basal cells, differentiating keratinocytes 
are less adherent to tissue-culture plastic [1], types I and IV collagen 
[2], and fibronectin and basement membranes [3]. This reduced 
cell-matrix adhesion suggests that keratinocyte stratification is ac-
companied by loss or modification of matrix receptors. Moreover, 
aggregation studies show that a mixture of differentiating keratino-
cytes and basal cells will sort themselves out in homotypic fashion, 
signifying preferential adhesion between cells at similar stages of 
differentiation [4]. Therefore, changes in cell-matrix and cell-cell 
adhesivity occur during keratinocyte differentiation and stratifica-
tion. 
The basis for these changes in keratinocyte adhesivity is not en-
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evaluated before and after calcium-induced stratification and 
differentiation. Cells growing as an unstratified monolayer 
express a higher molecular mass form of syndecan-1 than do 
stratified cells (modal relative mass of 160 kD versus 
110 kD) . This structural difference is due to larger and more 
heparan sulfate chains on syndecan-1 from monolayer cells . 
In addition, the amount of cell-surface syndecan-1 changes 
with stratification; stratified cultures show approximately 
2.5 times more syndecan-1 per cell than do unstratified cul-
tures, but do not significantly change the level of syndecan-
1-specific mRNA. Thus, the structure and amount of syn-
decan-1 may be regulated to meet the changing adhesive 
requirements of stratifying keratinocytes. ] Invest Dermatol 
99:390-396, 1992 . 
tirely clear, but is probably the result of cha.nges in many molecules 
that act in concert. For example, upon keratinocyte differentiation, 
quantitative and/or qualitative changes occur in desmosomes [4-
7], E- and P-cadherin [8-10], integrins [11-14], cell surface affinity 
for lectins [15-18] and proteoglycan content [19,20]. 
Syndecan-l, a member of a family of integral membrane proteo-
glycans, behaves as a matrix receptor and binder of growth factors 
[21]. Syndecan-l localizes to the basolateral surface of simple epith-
elia and binds these cells to extracellular matrix components includ-
ing fibronectin [22], interstitial collagens [23]' and thrombospondin 
[24]. When cross-linked at the cell surface, syndecan-1 associates 
with the actin cytoskeleton [25] and NMuMG cells made deficient 
in syndecan-l by transfection with antisense eDNA become fusi-
form in shape indicating that syndecan-l is required for the mainte-
nance of epithelial cell morphology [26]. 
Syndecan-1 is also expressed on stratified epithelia where it local-
!zes over t~e entir~ cell surface. Syndecan- l from stratified epithelia 
IS ~mal~er 111 relative molecular mass than syndecan-l from simple. 
epithelia (model values of92 vs 160 kD) due to a reduction in size 
and number of glycosaminoglycan chains [27]. Although the func-
tion of the smaller form of syndecan-1 that surrounds stratified 
epithelia is unknown, its pattern of expression suggests it may medi-
ate cell-cell adhesion. In addition, syndecan-1 and the heparin-
binding growth factor, bFGF, have a similar pattern of distribution 
in the epidermis [28,29], suggesting that syndecan-l heparan sulfate 
on these cells may mediate bFGF signal transduction, as does hepa-
ran sulfate on other cell types [30,31]. 
In the present study, we examined syndecan-1 expression on kera-
tinocytes that are maintained as a monolayer and then induced to 
stratify and differentiate by increasing the Ca++ concentration in 
the culture medium [5]. We find that syndecan-1 becomes smaller 
in size but increases in amount at the cell surface with keratinocyte 
stratification. These changes in syndecan-1 may be one mechanism 
used by differentiating cells to meet their changing adhesive and 
growth requirements. 
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MATERIALS AND METHODS 
Cell Culture Primary mouse keratinocytes were prepared and 
cultured by the method of Yuspa et al. [32]. Briefly, skins were 
removed from newborn BALB/c mice (1-2 days old), trypsinized 
for 6-12 h at 4· C and the dermis mechanically separated from the 
epidermis. Epidermal cells were dispersed by stirring and plated at 
4.2 X 106 cells per 60 mm culture dish in Delbecco's modification 
of Eagle's Minimal Essential Medium prepared without calcium 
chloride (Whittaker Bioproducts, Walkersville, MD) and contain-
ing 8% chelex-treated fetal calf serum, 100 U /ml penicillin, 100 
J1.gj rnl streptomycin and 0.07 mM calcium chloride. The following 
day, unattached cells were removed and fresh media containing 
0 .05 mM Ca++ was introduced. Under these conditions, cells reach 
confluence as a monolayer in 3 - 5 days and can be maintained in this 
proliferative stage even at high cell density. To induce stratification 
of keratinocytes, the calcium chloride concentration in the medium 
was increased to 1.2 mM. For radiolabeling, 100 ,uCi/ml H235S04 
(leN Biomedicals, Costa Mesa, CA) were added to the medium for 
48 h. 
bn.:rnunolocalization Immunolocalizations were with MoAb 
281-2, a rat anti-mouse IgG2a specific for an epitope on the extra-
cellular domain of the syndecan-l core protein [33]. Tissue was 
fixed in 3.7% paraformaldehyde, embedded in paraplast. sectioned, 
deparaffinized in xylene and re-hydrated in a graded se~ie.s of alco-
hols, including incubation in absolute methanol conta1l1lng 0.3% 
H 2 0 2 to block endogenous peroxidase activity. Sections were 
blocked with 190 ,ug/ml rabbit IgG followed by incubation over-
night at 4· C with 3.8 ,ug/mI281-2 or as a control, Mel-14 [34] , a rat 
anti-mouse monoclonal IgG2a specific for a lymphocyte homing 
receptor. Sections were washed six times in PBS and incubated with 
5 J1.g/ml biotinylated rabbit anti-rat IgG (no cross reaction. with 
mouse IgG; Vector Laboratories. Burlingame, CA) for 30 mmutes 
at room temperature. After washing, sections were incubated for 30 
minutes at room temperature with an avidinhorseradish peroxidase 
reagent prepared from a Vectastain Elite ABC kit (Vec.tor ~aborato­
ries). Reaction product was generated with 0.05% dlaml11obenzl-
dine tetrahydrochloride containing 0.015% H20 2 in PBS. Staining 
of sections was enhanced with 0.5% CUS04 in 0.9% N aCI for 5 
minutes. Following mounting with covers lips, photographs were 
taken with a Zeiss Photomicroscope II equipped with a blue HOY A 
49 rnm filter and using Kodak Tech Pan film. For immunofluores-
cence, primary keratinocytes (3 X 106 cells/35 mm dish) were 
added to preformed collagen gels [35] cast at a final collagen con-
centration of 1 mg/ml (rat tail. type I collagen). The cells and gel 
were submerged in culture media containing 1.2 mM calcium and, 
after 72 hours, the medium was removed from the cultures and 
ice-cold Tissue-Tek (Miles Scientific, Naperville, IL) was added to 
cells growing on collagen gels. After incubation for 30 minutes on 
ice, the gel was frozen with dry ice, removed from the culture dish 
and 6,um cryostat sections prepared. Following blocking with 10 
J1.gjml normal rat IgG, sections were incubated with biotinylated 
MoAb 281-2 (2,ug/ml) for 30 minutes, washed in PBS and incu-
bated with avidin/FITC (5 ,ug/ml) for 30 minutes . Following 
washing in PBS, sections were mounted in 90% glycerol, 10% PBS, 
and viewed on a Zeiss Photomicroscope II equipped with epifluore-
scence. Photographs were taken using Kodak Tri-X film exposed at 
ASA 800. 
Extraction of Cells and Tissues Cell layers were washed three 
times in ice-cold 10 mM TBS, pH 7.4, incubated with TBS con-
taining 0.5 mM EDT A and the cells dislodged from the dish with a 
cell scraper. Following washing of cells two times with ice-cold 
TBS, 0.5 mM EDT A, cell pellets were extracted with 6 M urea, 1 % 
Triton X-I00, 10 mM Tris-HCI (pH 7.4), 5 mM benzamidine, 
5 ruM N-ethylmaleimide, 1 mM PMSF, 0.5 mM EDTA, 5,ug/ml 
pepstatin A and 0.15 M NaCI (buffer A). Extracts were vortexed 
periodically during a 4 h incubation on ice then centrifuged at 
21,000 X g for 15 minutes at 4· C and the supernatants analyzed. 
For extraction of syndecan-l from newborn skin, tissue was placed 
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into ice-cold buffer immediately upon excision from the mouse and 
extracted as described above for cells. 
Purification of Syndecan-1 Extracts in buffer A were diluted 
with 50 mM TBS, pH 7.4 to a final concentration of 0.6 M urea, 
0.1% Triton X-I00. Monoclonal 281-2 bound to Sepharose 4B 
beads (281-2 beads) was added to diluted extracts and gently rocked 
overnight at 4· C. The following day, the beads were placed in a 
polyprep disposable column (Bio-Rad, Richmond, CA) and washed 
with 20 mM acetic acid (pH 3.1) to remove nonspecifically bound 
molecules. Syndecan-1 was isolated from conditioned media follow-
ing centrifugation and addition of I M Tris (pH 7.4) to a final con-
centration of 20 mM. 281 -2 beads were introduced, incubated and 
washed as above. For removal of glycosaminoglycan chains, synde-
can-l bound to 281-2 beads was incubated with 0.1 unit/ml of 
heparitin sulfate lyase (heparitinase; Seikagaku, Rockville, MD) or 
0.05 unit/ml chondroitin ABC lyase (ABCase; Seikagaku, Rock-
ville, MD) using previously described conditions [36]. Following 
digestions, beads were washed extensively with dH20. For prepara-
tion of samples for SDS-PAGE gels, syndecan-l was eluted from 
beads by boiling in SDS-PAGE sample buffer [2% SDS (wt/vol), 
5% glycerol (vol/vol) , 0.025% bromophenol blue, 140 mM Tris 
and 60 mM boric acid, pH 8.0]. 
SDS-PAGE and Western Blotting Syndecan-1 was fraction-
ated on a 3.8-20% SDS polyacrylamide gel containing urea and 
boric acid, as described by Koda et al. [23], and transferred by the 
method of Towbin et al. [37] to Gene-Trans (Plasco, Woburn, 
MA), a cationic nylon membrane. Membranes were then blocked 
with blotto [38] and probed overnight at 4 0 C with 125I-labeled 
antibody 281-2, washed and exposed to Kodak X-OMAT AR film 
at -80·C. 
Determination of Glycosaminoglycan Size Radiosulfate-la-
beled syndecan-l bound to 281-2 beads was treated with nitrous 
acid to remove heparan sulfate or chondroitinase to remove chon-
droitin sulfate [36], and the digested glycosaminoglycan was 
washed from the beads and collected. Glycosaminoglycan remain-
ing on syndecan-1 was released with the addition of 0.1 M sodium 
hydroxide in 1 M potassium borohydride for 24 hat 37"C. Glyco-
saminoglycan was fractionated on Sepharose CL-6B (Pharmacia) in 
a buffer of 2% (wt/vol) SDS, 0.15 M NaCI, 50 mM sodium acetate 
(pH 5.0) and 0.02% (wt/vol) sodium azide. Fractions were mixed 
with AquaMix (ICN Biomedicals, Costa Mesa, CA) scintillation 
mixture and radioactivity was quantitated by an LKB 1219 liquid 
scintillation counter. Size of the glycosaminoglycan chains was de-
termined by comparison with a molecular size calibration curve 
generated with chondroitin sulfate standards [39]. 
RNA Isolation and Northern Blotting RNA isolation and 
Northern blots were prepared as previously described [40]. Briefly, 
poly (A) RNA was extracted from cultured cells with 4 M guani-
dine isothiocyanate in 5 mM sodium citrate, pH 7.0,0.1 M 2-mer-
captoethanol, 0.5% N-lauryl sarcosine. Following purification by 
CsCI density centrifugation, phenol/chloroform extraction and 
oligo (dT)-cellulose chromatography, RNA was separated by elec-
trophoresis in a 1.2% agarose-formaldehyde gel. RNA was blotted 
to GeneScreen (New England Nuclear, Boston, MA) and rrobed 
with a RNA probe prepared by the in vitro transcription 0 the 5' 
EcoRI-SacI fragment of syndecan-l clone PM-4. 
Quantitation of Syndecan-1 Culture medium conditioned by 
stratified and unstratified keratinocytes was collected and centri-
fuged to remove cell debris. Cell layers were washed 3 - 4 times 
with ice-cold PBS, incubated with ice-cold PBS containing 0.5 mM 
EDT A, and the cells harvested from the dish with a cell scraper. To 
remove cell surface syndecan-l, the cells were pelleted by centrifu-
gation, resuspended in ice-cold PBS with 0.5 mM EDT A and ex-
posed to 20 ,ug/ml trypsin (Sigma, St. Louis, MO; 2X crystalized, 
Type III) for 5 minutes on ice with gentle agitation. Soybean trypsin 
inhibitor was then added to a final concentration of 100 ,ug/ml, cells 
were pelleted by centrifugation, and the supernatant containing 
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Figure 1. Syndecan-1 localization in newborn skin and cultured stratified 
keratinocytes. (A) Section of paraffin-embedded newborn mouse skin 
stained with antibody 281-2. Immunoperoxidase stain surrounds cells of the 
basal and spinous.layers, but is weak or absent in the region of contact with 
the basement membrane (arrows). Cells of the most superficial regions of the 
granular layer and cells within the cornified layer do not stain (arrowhead). 
(B) Immunofluorescence staining for syndecan-1 on a frozen section of 
cultured stratified keratinocytes growing on a type I collagen gel. The cell 
layer is 3 - 4 cells thick. Stain surrounds the individual cells, but is absent 
from the apical surface of cells in the most superficial layer (arrowheads). Bar, 
10 Jim. 
released syndecan-l analyzed by a previously described radioimmu-
noassay [41]. Briefly, a wet cationic membrane ( Gene-Trans) was 
placed into an immunodot apparatus (V & P Scientific, San Diego, 
CA) and samples of culture medium and trypsin-released cell surface 
material from stratified and unstratified cells were loaded onto the 
membrane using mild vacuum. Also loaded were known amounts of 
syndecan-l added to either culture medium unconditioned by cells 
(culture medium standards) or to PBS containing 0.5 mM EDTA, 
20 p,g/ ml trypsin and 100 p,g/ ml soybean trypsin inhibitor (trypsin-
released standards). After loading, the membrane was placed in 
0.025% glutaraldehyde to fix protein to the membrane. The mem-
brane was then rinsed briefly with distilled H 20, blocked with 
blotto, washed once with TBS pH 7.4 containing 1 % FCS and 
0.3% Tween 20 (buffer B), and then incubated overnight at 4 0 C in 
buffer B containing 125I-labeled MoAb 281-2. The membrane was 
washed six times in buffer B to remove unbound antibody, dried, 
and the dots cut out and counted in a gamma counter (Hewlett 
Packard, Palo Alto, CA). Quantity of DNA in the cell pellets re-
maining after trypsinization was determined by the method of Ka-
puscinski and Skoczylas [42]. 
RESULTS 
Keratinocytes in the Epidermis and in Culture Have a Simi-
lar Pattern ofSyndecan-l Expression To determine whether 
keratinocytes stratifying in vitro provide a useful system to study 
changes in syndecan-l expression, we compared syndecan-l locali-
zation in cross sections of newborn mouse skin and stratified cul-
tures of mouse keratinocytes. In the epidermis, syndecan-l 
surrounds the surfaces of basal, spinous and lower granular layers 
(Fig lA and [28,43]) . Staining is attenuated where basal cells contact 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
the substratum, becomes intense in the spinous layers and dimin-
ishes in the granular layers before disappearing completely in corni-
fied layers. No cells in the dermis stain. This pattern of syndecan-l 
expression is identical with that seen in other stratified epithelial 
tissues, such as the tongue and vagina [28]. The attenuation of 
staining for syndecan-l where basal cells contact the substratum 
may be due to masking of the 281-2 epitope because staining of 
murine skin with a polyclonal antisera to syndecan-l indicates that 
syndecan-l is present at this site [43] . 
Stratified keratinocytes growing on collagen gels in culture are 
three to four layers thick. Cross sections of these cultures reveal that 
syndecan-l surrounds the stratified cells but is absent from the apical 
surface of the most superficial cell layer (Fig lB), a pattern similar to 
that seen in vivo. 
Syndecan-l Size Decreases with Keratioocyte Stratifica-
tion To establish whether the molecular mass of syndecan-l 
changes with keratinocyte stratification, we compared syndecan-l 
extracted from monolayer and stratified cells . Radiosulfate was 
added to cultures maintained as mono layers (0.05 mM Ca++) and at 
this time, some monolayer cultures received media containing 
1.2 mM Ca++ to induce stratification. After 48 hours, the 35S04-la-
beled syndecan-l from monolayer and stratified cells was extracted, 
immunoisolated with MoAb 281-2 and its relative mass compared 
by SDS-PAGE. Syndecan-l migrates on PAGE as a smear, corre-
sponding to a range of molecular masses. Syndecan-l from mono-
layer cells is larger (model size approximately 160 kD) than that 
from stratified cells (approximately 110 kD; Fig 2). A similar dif-
ference in relative mass is seen with syndecan-l isolated from media 
conditioned by monolayer and stratified keratinocytes. Syndecan-l 
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Figure 2. Syndecan-1 decreases in size upon keratinocyte stratification. 
Radiolabeled syndecan-1 was extracted from cells growing as monolayers or 
48 h after calcium induced stratification. Monolayer and stratified cultures 
were of the same age. Syndecan-1 from cell extracts and culture media was 
isolated by 281-2 affinity purification followed by SDS-PAGE. For compari-
son, syndecan-1 from newborn skin was extracted and purified in an identi-
cal manner and visualized by Western blotting using 1251_281_2. 
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tha t of syndecan-1 extracted from keratinocytes stratifying in cul-
ture (Fig 2). 
syndecan-t Core Protein Size Does Not Change with Kera-
tinocyte Stratification The relative mass of the syndecan-1 core 
protein from monolayer and stratified keratinocytes was evaluated 
on Western blots. Following treatment with enzymes that remove 
both heparan sulfate and chondroitin sulfate chains, the syndecan-1 
core proteins from monolayer and stratified cells were identical in 
relative mass (approximately 69 kD; Fig 3). Bands migrating at 
higher molecular mass (approximately 140 kD) are seen following 
the enzyme digestions, possibly representing core protein aggre-
gates. 
Stratified cells, but not monolayer cells, express intact syndecan-1 
that migrates at the size of glycosaminoglycan-free core protein (Fig 
3; lanes 1 and 4). The majority of syndecan-1 from both monolayer 
and stratified cells appears to contain solely heparan sulfate because 
enzymatic removal of heparan sulfate only yields core protein 
bands. However, studies with 35S04-labeled syndecan-1 indicate 
that a small portion of the molecules from both cultures also contain 
chondroitin sulfate; no molecules were detected that contained 
solely chondroitin sulfate (data not shown). 
GlycosaminogJycan Composition of Syndecan-l Changes 
with Keratinocyte Stratification Syndecan-1 bound to im-
rnunobeads was treated with either heparitinase or chondroitinase 
and the residual glycosaminoglycan chains removed with alkali. 
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Figure J. Syndecan-l core protein size is identical on monolayer and strati-
fied cells. Western blot of syndecan-l before and after removal of glycosa-
nllnoglycan chains is shown. Syndecan-l was extracted, purified, and sub-
jected to SDS-PAGE following no treatment (intact syndecan-l), treatment 
W'ith heparitinase (HS Lyase) or with both heparitinase and chondroitinase 
(ABCase). Following transfer to a cationic nylon membrane, syndecan-l was 
detected with 12sI_labeled 281-2, which recognizes the core protein. 
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Figure 4. Syndecan-1 heparan sulfate chains are larger on monolayer than 
on stratified keratinocytes. Radiolabeled syndecan-l extracted from mono-
layer and stratified cells was prepared as in Fig 2 and treated with chondroi-
tinase to remove chondroitin sulfate. The heparan sulfate released from the 
core protein with alkali/potassium borohydride was then fractionated on 
Sepharose CL-6B in 2% SDS buffer. Heparan sulfate from monolayer kerati-
nocytes has a Kav of 0.43 and from stratified keratinocytes a Kav of 0.50. 
fate chains derived from monolayer keratinocytes behave as larger 
chains than those from stratified keratinocytes (modal size 34 vs . 
21 kD; Fig 4). Chondroitin sulfate represents only 5 -10% of the 
total radiosulfate-labeled glycosaminoglycan and the chains are 
identical in size (8 kD) on syndecan-1 from monolayer and strati-
fied keratinocytes (data not shown; cf. [271). Thus, assuming a simi-
lar extent of sulfation, the difference in syndecan-1 size between 
~nonolayer and st~atified cells is at least partially due to a difference 
m the Slze of thelr heparan sulfate chains. 
Amount of Syndecan-l at the Cell Surface Increases with 
Keratinocyte Stratification Syndecan-l localization in the epi-
dermis indicates that it is more abundant on suprabasal cells than on 
basal cells (Fig lA). Therefore, the amount of syndecan-l at the cell 
surface or shed into the culture medium was compared in mono-
layer and stratified cultures. Keratinocytes were grown to con-
fluence as monolayers in 0.05 mM Ca++ (3 to 5 d) and then induced 
to stratify for 2 d by raising the Ca++ to 1.2 mM. Medium was then 
changed for all cultures and the cells incubated an additional 24 h, 
after which syndecan-1 on the cell surface or shed into the culture 
medium was quantitated by radioimmunoassay. After stratification, 
the amount of syndecan-l per cell increases approximately 2.5-fold 
at the cell surface and in the culture medium (Table I). 
Abundance ofSyndecan-l mRNA Does Not Change Signifi-
cantly with Keratinocyte Stratification Syndecan-l mRNA 
levels in monolayer and stratified cultures were measured to deter-
mine if the change in amount and size of syndecan-1 after stratifica-
tion correlates with a change in syndecan-l-specific mRNA. Equal 
amounts of poly(A) RNA from monolayer and stratified cultures 
(48 h) were examined by Northern blot with an RNA probe specific 
for syndecall-l mRNA. The resulting autoradiogram (Fig 5) reveals 
syndecan-1 mRN A is present in similar relative abundance in both 
cultures (1.2-fold increase with stratification). Thus, the changes in 
syndecan-l seen after stratification are apparently controlled by 
394 SANDERSON ET AL 



















• Syndecan- l from monolayer and stratified keratinocytes growing in culture was 
purified and the amount of syndecan-l per Ilg of DNA was determined as described in 
Materials atld Methods. 
post-transcriptional mechanisms. The two species of syndecan-1 
mRNA detected at 2.6 and 3.4 kb are consistent with previously 
reported results [40]. 
DISCUSSION 
Keratinocyte cohesiveness changes during passage from basal to 
cornified layers. We now find that the structure and amount of cell 
surface syndecan-1 are altered during keratinocyte stratification in 
vitro . The results suggest that syndecan-l is regulated at both the 
molecular and cellular levels to meet the changing adhesive require-
ments of keratinocytes during differentiation and stratification. 
In this study, the alterations in syndecan-1 found in monolayer 
and stratified cultures are probably less extensive than the actual 
differences between basal and supra basal keratinocytes in the epider-
mis. Stratified cultures retain a layer of undifferentiated basal cells 
while monolayer cultures contain some differentiating cells that are 
prevented from stratifying by the low Ca++ [1]. Therefore, because 
the monolayer and stratified cultures used here contain mixed popu-
lations of basal (undifferentiated) and suprabasal (differentiating) 
cells, the observed in vitro changes in syndecan-l structure and 
amount likely underestimate those occurring in vivo. 
Relative to monolayer cells, syndecan-l from stratified keratino-
cytes is partly free of glycosaminoglycan chains and is lower in 
relative mass (approximately 110versus 160 kD) with smaller hepa-
ran sulfate chains (approximately 21 versus 34 kD) on the same size 
core protein (approximately 69 kD). However, differences in hepa-
ran sulfate chain size alone cannot account for the difference in 
relative mass; syndecan-l from stratified cells must also contain 
fewer heparan sulfate chains. We cannot rule out the possibility that 
the reduction in heparan sulfate chain size is due in part to increased 
heparitinase activity in stratified cultures. However, if the differ-
ence in heparan sulfate size was due to heparitinase, it is likely that 
heparan sulfate from stratified cultures would have a broader size 
distribution than that of heparan sulfate from monolayer cultures. 
However, data in Fig 4 indicate that although the size of heparan 
sulfate from stratified and monolayer cells differs, the heparan sul-
fate from stratified cells does not exhibit a broader distribution in 
size than that of heparan sulfate from monolayer cultures. 
These results extend our previous finding that syndecan-1 from 
different tissue . types exhibits a molecular polymorphism which 
correlates with tissue organization [27] . That is, syndecan-1 from 
simple epithelia (approximately 160 kD) is larger in size and has a 
greater number of heparan sulfate and chondroitin sulfate chains 
than that from stratified epithelia (approximately 92 kD) . By mani-
pu lating keratinocyte morphology in vitro we have now tested 
whether syndecan-1 polymorphism is primarily due to tissue type or 
to cellular organization. Our results establish that in epidermal kera-
tinocytes, changes in syndecan-1 structure are determined by cellu-
lar organization and/or differentiation. 
On a per cell basis, stratified keratinocytes contain up to two and a 
half times the amount of cell surface syndecan-1 than monolayer 
keratinocytes (Table I), although the density of syndecan-1 on 
monolayer and stratified cells may be similar because cell surface 
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area increases upon stratification [44,45). However, an increase in 
syndecan-1 amount is consistent with the reported increase in prote-
oglycan synthesis during epidermal differentiation [19] despite an 
overall decrease of 60% in non-specific protein synthesis [5]. This 
increase in syndecan-1 amount is not due to increased retention of 
cell surface syndecan-l because syndecan-l shed into the culture 
medium increases to the same extent. Nor is the increase due to 
retention of shed syndecan-1 between cell layers. The shed proteo-
glycan lacks the transmembrane and cytoplasmic domains and mi-
grates at 56 kD [41], whereas the core protein from stratified layers 
migrates as an intact core protein at 69 kD [27) and Fig 3, even 
when the cell layers are extracted without prior washing (data not 
shown). 
The functional significance of changes in syndecan-1 molecular 
structure and abundance is not well understood. However, recent 
studies comparing NMuMG (epithelial) and MPC-ll (B lymph-
oid) syndecan-l demonstrate that the 160 kD form of syndecan-1 
isolated from NMuMG cells has greater than a four-fold higher 
affinity for type I collagen than does the 85 kD form of syndecan-1 
isolated from MPC-ll cells [46]. Similarly, a high molecular 
weight form of syndecan-1 from embryonic tooth mesenchyme 
binds to tenascin better than syndecan-1 from NMuMG cells [47]. 




















Figure 5. The size and relative abundance of syndecan-l mRNA is similar 
in monolayer and stratified keratinocytes. Poly (A) RNA was isolated from 
monolayer and stratified cells, and equal amounts were loaded on a 1.2% 
agarose-formaldehyde gel. The RNA was transferred and hybridized as 
described in Materials mId Methods. Scanning densitometry indicates that the 
mRNA detected from stratified cells is 1.2 times more abundant than that 
from monolayer cells. 
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differences in glycosaminoglycan chain size and/or comrosition 
can affect the interactions of proteoglycans with a variety 0 ligands 
[48,49J. 
In addition to the changes in syndecan-l structure and abundance 
described in the present work, similar changes occur with cell trans-
forma tion. Transformed NMuMG cells express a smaller form of 
syndecan-1, pile up in culture and are highly invasive when injected 
into athymic nude mice, while their non-transformed counterparts 
express the larger 160 kD form of syndecan-1, grow as monolayers 
in culture and are non-invasive [50,51] . Loss or reduction in synde-
can-1 expression occurs following hormone-induced transforma-
tion of simple epithelia [52] and in skin tumors induced by ultravio-
let irra diation [53]. Thus, in addition to mediating adhesive changes 
during normal cell differentiation, changes in syndecan-l structure 
and/or amount at the cell surface may be important in tumor 
gro"Wth and metastasis. 
The changes in syndecan-1 expression seen during keratinocyte 
stratification may signify a change in syndecan-1 adhesive function. 
The larger, heparan sulfate-rich syndecan-l molecules found on the 
monolayer cells may be involved in cell-matrix interactions, as seen 
in simple epithelia such as mammary epithelial cells. On the other 
hand, the more abundant, smaller, heparan sulfate-poor syndecan-1 
found on the stratified cells may be involved predominantly in 
cell-cell adhesion. Interestingly, removal of syndecan-1 glycosa-
minoglycan chains results in what appears to be core protein aggre-
gates (see Fig 3) . Recent studies suggest syndecan-2 from the rat 
liver may also form aggregates following the removal of glycosa-
minoglycan chains [54]. Finally, loss of syndecan-1 on terminally 
differentiated cells may permit desquamation. 
Changes in syndecan-1 expression may also modulate the expres-
sion of other keratinocyte adhesion molecules. Mammary epithelial 
cells made deficient in cell surface syndecan-1 by transfection with 
an antisense eDNA construct become fusiform in morphology, lose 
expression of E-cadherin, and show a redistribution of fJ1 -integrins 
[55]. If syndecan-1 acts similarly in epidermal keratinocytes, synde-
can-l may be involved in the regulation ofE-cadherin and fJl-inte-
grin expression and could orchestrate their roles in differentiation 
and stratification. 
In addition to its role in adhesion, syndecan-1 also binds to bFGF 
[21,56,57] and likely binds to other members of the heparin-bind-
ing growth factor family, such as keratinocyte growth factor [58] . 
Because binding of these growth factors to heparan sulfate may be 
required for growth factor-mediated signal transduction [30,31 J, 
their action on keratinocytes could be temporally and spatially re-
stricted by the expression of syndecan-1. For instance, syndecan-l 
may retain bFGF at the cell surface as the keratinocytes stratify and 
move away from the reservoir ofbFGF in the basement membrane. 
Also, the recent finding that syndecan-1 increases in abundance on 
proliferating keratinocytes during wound healing suggests that syn-
decan-l may rarticipate in growth factor-mediated repair of the 
epidermis [59 . 
In conclusion, syndecan-l is a well characterized cell-matrix re-
ceptor in simple epithelia that changes in structure and quantity 
when keratinocytes stratify. These changes imply that syndecan-l 
has an alternative function in the epidermis, perhaps as a cell-cell 
adhesion and/or growth factor binding molecule. Thus, syndecan-
1 could play a role in altering the cellular interactions that are 
characteristic of epidermal differentiation and stratification, 
This study was supported by a gratJl frol1l the A;thritis FouMdatiolJ (RDS) a/Jd by 
National 1t1Stillltes oj Health gralJts AR01816 (MTH) al1d HD06763 (MB). 
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